Back to search

Article

CSF glucosylsphingosine is a central readout of GCase impairment across genetic and sporadic Parkinson’s disease

2026-06-22

Abstract excerpt

Parkinson’s disease (PD) risk converges on lysosomal biology, including reduced activity of glucocerebrosidase (GCase), encoded by GBA1 . Glucosylsphingosine (GlcSph), a toxic deacylated glycosphingolipid and established target engagement biomarker in Gaucher disease, is difficult to quantify in cerebrospinal fluid (CSF) because of low abundance and isomeric interference. We optimized and qualified targeted LC–MS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f8438cd7-9f5b-5f90-afcd-0fa336c26180
DOI
10.64898/2026.06.19.733447
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CSF glucosylsphingosine is a central readout of GCase impairment across genetic and sporadic Parkinson’s diseaseDOI 10.64898/2026.06.19.733447
Select a neighboring publication to make it the new centre.